Current perspectives on the clinical management of cryptogenic stroke

References

• Saver J, Solomon CG. Clinical practice. Cryptogenic stroke. N Engl J Med. 2016;374(21):2065–2074.
   PubMedGoogle Scholar
• Kunitz SC, Gross CR, Heyman A, et al. The pilot stroke data bank: definition, design, and data. Stroke. 1984;15(4):740–746.
   PubMedGoogle Scholar
• Adams JHP, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke. 1993;24(1):35–41.
   PubMed Web of Science ®Google Scholar
• Schneider AT, Kissela B, Woo D, et al. Ischemic stroke subtypes: a population-based study of incidence rates among blacks and white. Stroke. 2004;35(7):1552.
   PubMedGoogle Scholar
• Lee BI, Nam HS, Heo JH, et al. Yonsei stroke registry: analysis of 1000 patients with acute cerebral infarctions. Cerebrovasc Dis. 2001;12(3):145.
   PubMedGoogle Scholar
• Ornello R, Degan D, Tiseo C, et al. Distribution and temporal trends from 1993 to 2015 of ischemic stroke subtype: a systemic review and meta-analysis. Stroke. 2018;49(4):814.
   PubMedGoogle Scholar
• Sacco RL, Ellenberg JH, Mohr JP, et al. Infarcts of undetermined cause: the NINCDS stroke data bank. Ann Neurol. 1989;25(4):382–390.
   PubMed Web of Science ®Google Scholar
• Boeckh-Behrens T, Kleine JF, Zimmer C, et al. Thrombus histology suggests cardioembolic cause in cryptogenic stroke. Stroke. 2016;47(7):1864.
   PubMed Web of Science ®Google Scholar
• Ay H, Furie KL, Singhal A, et al. An evidence-based causative classification system for acute ischemic stroke. Ann Neurol. 2005;58(5):688.
   PubMed Web of Science ®Google Scholar
• Ay H, Benner T, Arsava EM, et al. A computerized algorithm for etiologic classification of ischemic stroke: the causative classification of stroke system. Stroke. 2007;38(11):2979.
   PubMed Web of Science ®Google Scholar
• Amarenco P, Bogousslavsky J, Caplan LR, et al. A new approach to stroke subtyping: the A-S-C-O (phenotypic) classification of stroke. Cerebrovasc Dis. 2009;27(5):502–508.
   PubMed Web of Science ®Google Scholar
• Gordon DL, Bendixen BH, Adams JHP, et al. Interphysician agreement in the diagnosis of subtypes of acute ischemic stroke: implications for clinical trials. The TOAST investigators. Neurology 1993;43(5):1021–1027.
   PubMed Web of Science ®Google Scholar
• Amarenco P, Bogousslavsky J, Caplan LR, et al. The ASCOD phenotyping of ischemic stroke (updated ASCO phenotyping). Cerebrovasc Dis. 2013;36(1):1–5.
   PubMed Web of Science ®Google Scholar
• Marnane M, Duggan CA, Sheehan OC, et al. Stroke subtype classification to mechanism-specific and undetermined categories by TOAST, A-S-C-O, and causative classification system: direct comparison in the North Dublin population stroke study. Stroke. 2010;41(8):1579–1586.
   PubMed Web of Science ®Google Scholar
• Hart RG, Diener HC, Coutts SB, et al. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014;13(4):429–438.
   PubMed Web of Science ®Google Scholar
• Hart RG, Sharma M, Mundl H, et al. Rivaroxaban for stroke prevention after embolic stroke of undetermined source. N Engl J Med. 2018;378(23):2191–2201.
   PubMed Web of Science ®Google Scholar
• Diener HC, Sacco RL, Easton JD, et al. Dabigatran for prevention of stroke after embolic stroke of undetermined source. N Engl J Med. 2019;380(20):1906–1917.
   PubMed Web of Science ®Google Scholar
• Kamel H, Longstreth WT Jr, Tirschwell DL, et al. The atrial cardiopathy and antithrombotic drugs in prevention after cryptogenic stroke randomized trial: rationale and methods. Int J Stroke. 2019;14(2):207–214.
   PubMed Web of Science ®Google Scholar
• Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 guideline for the prevention of stroke in patients with stroke and transient attack: a guideline from the American Heart Association/American Stroke Association. Stroke. 2021;52(7):e364–e467.
   PubMed Web of Science ®Google Scholar
• Chalela JA, Kidwell CS, Nentwich LM, et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet. 2007;369(9558):293–298.
   PubMed Web of Science ®Google Scholar
• Koelemay MJ, Nederkoorn PJ, Reitsma JB, et al. Systematic review of computed tomographic angiography for assessment of carotid artery disease. Stroke. 2004;35(10):2306–2312.
   PubMedGoogle Scholar
• Debrey SM, Yu H, Lynch JK, et al. Diagnostic accuracy of magnetic resonance angiography for internal carotid artery disease: a systematic review and meta-analysis. Stroke. 2008;39(8):2237–2248.
   PubMedGoogle Scholar
• Wardlaw JM, Chappell FM, Best JJK, et al. Non-invasive imaging compared with intra-arterial angiography in the diagnosis of symptomatic carotid stenosis: a meta-analysis. Lancet. 2006;367(9521):1503–1512.
   PubMedGoogle Scholar
• McGrath ER, Paikin JS, Motlagh B, et al. Transesophageal echocardiography in patients with cryptogenic ischemic stroke: a systematic review. Am Heart J. 2014;168(5):706–712.
   PubMedGoogle Scholar
• Mohr JP, Thompson JL, Lazar RM, et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med. 2001;345(20):1444–1451.
   PubMed Web of Science ®Google Scholar
• Sacco RL, Prabhakaran S, Thompson JL, et al.; WARSS Investigators. Comparison of warfarin versus aspirin for the prevention of recurrent stroke or death: subgroup analyses from the warfarin-aspirin recurrent stroke study. Cerebrovasc Dis. 2006;22(1):4–12.
   PubMed Web of Science ®Google Scholar
• Healey JS, Gladstone DJ, Swaminathan B, et al. Recurrent stroke with rivaroxaban compared with aspirin according to predictors of atrial fibrillation: secondary analysis of the NAVIGATE ESUS randomized clinical trial. JAMA Neurol. 2019;76(7):764–773.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013;369(1):11–19.
   PubMed Web of Science ®Google Scholar
• Johnston SC, Easton JD, Farrant M, et al. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med. 2018;379(3):215–225.
   PubMed Web of Science ®Google Scholar
• Sposato LA, Cipriano LE, Saposnik G, et al. Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol. 2015;14(4):377–387.
   PubMed Web of Science ®Google Scholar
• Boriani G, Vitolo M, Imberti JF, et al. What do we do about atrial high rate episodes? Eur Heart J Suppl. 2020;22(SupplO):O42–O52.
   PubMedGoogle Scholar
• Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012;366(2):120.
   PubMed Web of Science ®Google Scholar
• Gladstone DJ, Spring M, Dorian P, et al. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med. 2014;370:2467–2477.
   PubMed Web of Science ®Google Scholar
• Sanna T, Diener HC, Passman RS, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370:2478–2486.
   PubMed Web of Science ®Google Scholar
• Favilla CG, Ingala E, Jara J, et al. Predictors of finding occult atrial fibrillation after cryptogenic stroke. Stroke. 2015;46(5):1210–1215.
   PubMed Web of Science ®Google Scholar
• Suzuki S, Sagara K, Otsuka T, et al. Usefulness of frequent supraventricular extrasystoles and a high CHADS2 score to predict first-time appearance of atrial fibrillation. Am J Cardiol. 2013;111(11):1602–1607.
   PubMed Web of Science ®Google Scholar
• Diederichsen SZ, Haugan KJ, Brandes A, et al. Incidence and predictors of atrial fibrillation episodes as detected by implantable loop recorder in patients at risk: from the LOOP study. Am Heart J. 2020;219:117–127.
   PubMed Web of Science ®Google Scholar
• Svendsen JH, Diederichsen SZ, Hojberg S, et al. Implantable loop recorder detection of atrial fibrillation to prevent stroke (the LOOP Study): a randomized control trial. Lancet. 2021;398(10310):1507–1516.
   PubMed Web of Science ®Google Scholar
• Lu Z, Scherlag BJ, Lin J, et al. Atrial fibrillation begets atrial fibrillation: autonomic mechanism for atrial electrical remodeling induced by short-term rapid atrial pacing. Circ Arrhythm Electrophysiol. 2008;1(13):184–192.
   PubMedGoogle Scholar
• Culebras A, Messé SR. Summary of evidence-based guideline update: prevention of stroke in nonvalvular atrial fibrillation: report of the guideline development subcommittee of the American Academy of Neurology. Neurology. 2014;83(13):1220.
   PubMedGoogle Scholar
• Lopes RD, Alings M, Connolly SJ, et al. Rationale and design of the apixaban for the reduction of thrombo-embolism in patients with device-detected sub-clinical Atrial Fibrillation (ARTESiA) trial. Am Heart J. 2017;189:137–145.
   PubMed Web of Science ®Google Scholar
• Kirchhof P, Blank BF, Calvert M, et al. Probing oral anticoagulation in patients with atrial high rate episodes: rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial. Am Heart J. 2017;190:12–18.
   PubMed Web of Science ®Google Scholar
• Elkind MSV. Atrial cardiopathy and stroke prevention. Curr Cardiol Rep. 2018;20(11):103.
   PubMedGoogle Scholar
• Al-Khatib SM, Allen Lapointe NM, Chatterjee R, et al. Rate- and rhythm-control therapies in patients with atrial fibrillation: a systematic review. Ann Intern Med. 2014;160(11):760–773.
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, D’Agostino RB, Belanger AJ, et al. Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation 1995;92(4):835–841.
   PubMed Web of Science ®Google Scholar
• Yaghi S, Moon YP, Mora-McLaughlin C, et al. Left atrial enlargement and stroke recurrence: the Northern manhattan stroke study. Stroke. 2015;46(6):1488–1493.
   PubMed Web of Science ®Google Scholar
• Kamel H, Hunter M, Moon YP, et al. Electrocardiographic left atrial abnormality and risk of stroke: Northern Manhattan Study. Stroke. 2015;46(11):3208–3212.
   PubMed Web of Science ®Google Scholar
• Binici Z, Intzilakis T, Nielsen OW, et al. Excessive supraventricular ectopic activity and increased risk of atrial fibrillation and stroke. Circulation. 2010;121(17):1904–1911.
   PubMed Web of Science ®Google Scholar
• Kamel H, Elkind MS, Bhave PD, et al. Paroxysmal supraventricular tachycardia and the risk of ischemic stroke. Stroke. 2013;44(6):1550–1554.
   PubMed Web of Science ®Google Scholar
• Folsom AR, Nambi V, Bell EJ, et al. Troponin T, N-terminal pro-B-type natriuretic peptide, and incidence of stroke: the atherosclerosis risk in communities study. Stroke. 2013;44(4):961–967.
   PubMed Web of Science ®Google Scholar
• Kamel H, Okin PM, Elkind MSV, et al. Atrial fibrillation and mechanisms of stroke: time for a new model. Stroke. 2016;47(3):895–900.
   PubMed Web of Science ®Google Scholar
• Di Biase L, Santangeli P, Anselmino M, et al. Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. J Am Coll Cardiol. 2012;60(6):531–538.
   PubMed Web of Science ®Google Scholar
• Yaghi S, Boehme AK, Hazan R, et al. Atrial cardiopathy and cryptogenic stroke: a cross-sectional pilot study. J Stroke Cerebrovasc Dis. 2016;25(1):110–114.
   PubMed Web of Science ®Google Scholar
• Kamel H, Bartz TM, Elkind MSV, et al. Atrial cardiopathy and the risk of ischemic stroke in the CHS (Cardiovascular Health Study). Stroke. 2018;49(4):980–986.
   PubMed Web of Science ®Google Scholar
• Prior IA, Trial CS. ESOC 2022 – Late breaking science, ongoing trials & young stroke physicians and researchers. Eur Stroke J. 2022;7(1 Suppl):546–588.
   Google Scholar
• Mas JL. Patent foramen ovale, atrial septal aneurysm and ischaemic stroke in young adults. Eur Heart J. 1994 Apr;15(4):446–449.
   PubMed Web of Science ®Google Scholar
• Meer I, Whisnant JP, Khandheria BK, et al. Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke prevention: assessment of risk in a community. Mayo Clin Proc. 1999;74(9):862–869.
   PubMedGoogle Scholar
• Pearson AC, Nagelhout D, Castello R, et al. Atrial septal aneurysm and stroke: a transesophageal echocardiographic study. J Am Coll Cardiol. 1991;18(5):1223–1229.
   PubMedGoogle Scholar
• Cabanes L, Mas JL, Cohen A, et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke. 1993;24(12):1865–1873.
   PubMed Web of Science ®Google Scholar
• Kent DM, Ruthazer R, Weimar C, et al. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology. 2013;81(7):619–625.
   PubMed Web of Science ®Google Scholar
• Elgendy AY, Saver JL, Amin Z, et al. Proposal for updated nomenclature and classification of potential causative mechanism in patent foramen ovale-associated stroke. JAMA Neurol. 2020;77(7):878–886.
   PubMed Web of Science ®Google Scholar
• Abushora MY, Bhatia N, Alnabki Z, et al. Intrapulmonary shunt is a potentially unrecognized cause of ischemic stroke and transient ischemic attack. J Am Soc Echocardiogr. 2013;26(7):683–690.
   PubMedGoogle Scholar
• Caputi L, Carriero MR, Falcone C, et al. Transcranial Doppler and transesophageal echocardiography: comparison of both techniques and prospective clinical relevance of transcranial Doppler in patent foramen ovale detection. J Stroke Cerebrovasc Dis. 2009;18(5):343–348.
   PubMedGoogle Scholar
• Schneider B, Zienkiewicz T, Jansen V, et al. Diagnosis of patent foramen ovale by transesophageal echocardiography and correlation with autopsy findings. Am J Cardiol. 1996;77(14):1202–1209.
   PubMed Web of Science ®Google Scholar
• Homma S, Sacco RL, Di Tullio MR, et al. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in cryptogenic stroke study. Circulation. 2002;105(22):2625–2631.
   PubMed Web of Science ®Google Scholar
• Furlan AJ, Reisman M, Massaro J, et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med. 2012;366(11):991–999.
   PubMed Web of Science ®Google Scholar
• Meier B, Kalesan B, Mattle HP, et al. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med. 2013;368(12):1083–1091.
   PubMed Web of Science ®Google Scholar
• Carroll JD, Saver JL, Thaler DE, et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med. 2013;368(12):1092–1100.
   PubMed Web of Science ®Google Scholar
• Saver JL, Carroll JD, Thaler DE, et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med. 2017;377(11):1022–1032.
   PubMed Web of Science ®Google Scholar
• Søndergaard L, Kasner SE, Rhodes JF, et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med. 2017;377(11):1033–1042.
   PubMed Web of Science ®Google Scholar
• Mas JL, Derumeaux G, Guillon B, et al. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N Engl J Med. 2017;377(11):1011–1021.
   PubMed Web of Science ®Google Scholar
• Kent DM, Saver JL, Kasner SE, et al. Heterogeneity of treatment effects in an analysis of pooled individual patient data from randomized trials of device closure of patent foramen ovale after stroke. JAMA. 2021;326(22):2277–2286.
   PubMedGoogle Scholar
• Messe SR, Gronseth GS, Kent DM, et al. Practice advisory update summary: patent foramen ovale and secondary stroke prevention: report of the guideline subcommittee of the American Academy of Neurology. Neurology. 2020;94(20):876–885.
   PubMed Web of Science ®Google Scholar
• Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics-2022 update: a report from the american heart association. Circulation. 2022;146(10):e141.
   PubMedGoogle Scholar
• Hays AG, Sacco RL, Rundek T, et al. Left ventricular systolic dysfunction and the risk of ischemic stroke in a multiethnic population. Stroke. 2006;37:1715–1719.
   PubMed Web of Science ®Google Scholar
• Lip GY, Ponikowski P, Andreotti F, et al. Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A joint consensus document from the ESC Heart Failure Association and the ESC working group on thrombosis. Eur J Heart Fail. 2012;14(7):681–695.
   PubMedGoogle Scholar
• Kannel WB, Wolf PA, Verter J. Manifestations of coronary disease predisposing to stroke. The framingham study. JAMA. 1983;250(21):2942–2946.
   PubMedGoogle Scholar
• Abdul-Rahim AH, Perez AC, Fulton R, et al. Risk of stroke in chronic heart failure patients without atrial fibrillation: analysis of the controlled rosuvastatin in multinational trial heart failure (corona) and the Gruppo Italiano per lo Studio della Sopravvivenza nell’Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials. Circulation. discussion 1494. 2015;131(17):1486–1494.
   PubMedGoogle Scholar
• Sandhu RK, Hohnloser SH, Pfeffer MA, et al. Relationship between degree of left ventricular dysfunction, symptom status, and risk of embolic events in patients with atrial fibrillation and heart failure. Stroke. 2015;46(3):667–672.
   PubMed Web of Science ®Google Scholar
• Lip GY, Gibbs CR. Does heart failure confer a hypercoagulable state? Virchow’s triad revisited. J Am Coll Cardiol. 1999;33(5):1424–1426.
   PubMed Web of Science ®Google Scholar
• Lam CS, Brutsaert DL. Endothelial dysfunction: a pathophysiologic factor in heart failure with preserved ejection fraction. J Am Coll Cardiol. 2012;60(18):1787–1789.
   PubMedGoogle Scholar
• Massie BM, Collins JF, Ammon SE, et al. Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial. Circulation. 2009;119(12):1616.
   PubMed Web of Science ®Google Scholar
• Homma S, Thompson JL, Pullicino PM, et al. Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med. 2012;366(20):1859.
   PubMed Web of Science ®Google Scholar
• Zannad F, Anker SD, Byra WM, et al. Rivaroxaban in patients with heart failure, sinus rhythm, and coronary disease. N Engl J Med. 2018;379(14):1332.
   PubMed Web of Science ®Google Scholar
• Mehra MR, Vaduganathan M, Fu M, et al. A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial. Eur Heart J. 2019;40(44):3593–3602.
   PubMedGoogle Scholar
• Ospel JM, Singh N, Marko M, et al. Prevalence of nonstenotic carotid plaques on computed tomography angiography in embolic stroke of undetermined source. Stroke. 2020;51(6):1743.
   PubMedGoogle Scholar
• Kamel H, Navi BB, Merkler AE, et al. Reclassification of ischemic stroke etiological subtypes on the basis of high-risk nonstenosing carotid plaque. Stroke. 2020;51(2):504–510.
   PubMedGoogle Scholar
• Kamel H, Gialdini G, Baradaran H, et al. Cryptogenic stroke and nonstenosing intracranial calcified atherosclerosis. J Stroke Cerebrovasc Dis. 2017;26(4):863–870.
   PubMedGoogle Scholar
• Goyal M, Singh N, Marko M, et al. Embolic stroke of undetermined source and symptomatic nonstenotic carotid disease. Stroke. 2020;51(4):1321.
   PubMedGoogle Scholar
• Zhao X, Hippe DS, Rui L, et al. Prevalence and characteristics of carotid artery high-risk atherosclerotic plaques in Chinese patients with cerebrovascular symptoms: a Chinese atherosclerosis evaluation II study. J Am Heart Assoc. 2017;6(8):e005831.
   PubMedGoogle Scholar
• Gutierrez J, Khasiyev F, Liu M, et al. Determinants and outcomes of asymptomatic intracranial atherosclerotic stenosis. J Am Coll Cardiol. 2021;78(6):562–571.
   PubMedGoogle Scholar
• Suri MF, Qiao Y, Ma X, et al. Prevalence of intracranial atherosclerotic stenosis using high-resolution magnetic resonance angiography in the general population: the atherosclerosis risk in communities study. Stroke. 2016;47(5):1187–1193.
   PubMedGoogle Scholar
• Von Sarnowski B, Schminke U, Tatisumak T, et al. Prevalence of stenoses and occlusions of brain-supplying arteries in young stroke patients. Neurology. 2013;80(14):1287–1294.
   PubMedGoogle Scholar
• Uchiyama S, Toyoda K, Kitagawa K, et al. Branch atheromatous disease diagnosed as embolic stroke of undetermined source: a sub-analysis of NAVIGATE ESUS. Int J Stroke. 2019;14(9):915–922.
   PubMedGoogle Scholar
• Song JW, Pavlou A, Xiao J, et al. Vessel wall magnetic resonance imaging biomarkers of symptomatic intracranial atherosclerosis: a meta-analysis. Stroke. 2021;52(1):193–202.
   PubMedGoogle Scholar
• Rerkasem A, Orrapin S, Howard DP, et al. Carotid endarterectomy for symptomatic carotid stenosis. Cochrane Database Syst Rev. 2020;9(9):CD001081.
   PubMedGoogle Scholar
• Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352(13):1305–1316.
   PubMed Web of Science ®Google Scholar
• Agmon Y, Khandheria BK, Meer I, et al. Relation of coronary artery disease and cerebrovascular disease with atherosclerosis of the thoracic aorta in the general population. Am J Cardiol. 2002;89(3):262–267.
   PubMedGoogle Scholar
• Davies MJ, Richardson PD, Woolf N, et al. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J. 1993;69(5):377.
   PubMedGoogle Scholar
• Macleod MR, Amarenco P, Davis SM, et al. Atheroma of the aortic arch: an important and poorly recognised factor in the aetiology of stroke. Lancet Neurol. 2004;3(7):408–414.
   PubMedGoogle Scholar
• Petty GW, Khandheria BK, Meer I, et al. Population-based study of the relationship between atherosclerotic aortic debris and cerebrovascular ischemic events. Mayo Clin Proc. 2006;81(5):609–614.
   PubMedGoogle Scholar
• Amarenco P, Cohen A, Tzourio C, et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med. 1994;331(22):1474–1479.
   PubMed Web of Science ®Google Scholar
• Tunick PA, Perez JL, Kronzon I. Protruding atheromas in the thoracic aorta and systemic embolization. Ann Intern Med. 1991;115:423–427.
   PubMed Web of Science ®Google Scholar
• Di Tullio MR, Sacco RL, Savoia MT, et al. Aortic atheroma morphology and the risk of ischemic stroke in a multiethnic population. Am Heart J. 2000;139(2 Pt 1):329–336.
   PubMedGoogle Scholar
• Chan KL. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. The stroke prevention in atrial fibrillation investigators committee on echocardiography. Ann Intern Med. 1998;128(8):639–647.
   PubMedGoogle Scholar
• Amarenco P, Davis S, Jones EF, et al. Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques. Stroke. 2014;45(5):1248–1257.
   PubMed Web of Science ®Google Scholar
• Stern A, Tunick PA, Culliford AT, et al. Protruding aortic arch atheromas: risk of stroke during heart surgery with and without aortic arch endarterectomy. Am Heart J. 1999t;138(4 Pt 1):746–752.
   PubMedGoogle Scholar
• Navi BB, Reiner AS, Kamel H, et al. Risk of arterial thromboembolism in patients with cancer. J Am Coll Cardiol. 2017;70(8):926–938.
   PubMed Web of Science ®Google Scholar
• Navi BB, Howard G, Howard VJ, et al. New diagnosis of cancer and the risk of subsequent cerebrovascular events. Neurology. 2018;90(23):e2025–e2033.
   PubMedGoogle Scholar
• Navi BB, Kasner SE, Elkind MSV, et al. Cancer and embolic stroke of undetermined source. Stroke. 2021;52(3):1121–1130.
   PubMed Web of Science ®Google Scholar
• Navi BB, Reiner AS, Kamel H, et al. Arterial thromboembolic events preceding the diagnosis of cancer in older persons. Blood. 2019;133(8):781–789.
   PubMedGoogle Scholar
• Cocho D, Gendre J, Boltes A, et al. Predictors of occult cancer in acute ischemic stroke patients. J Stroke Cerebrovasc Dis. 2015;24(6):1324–1328.
   PubMedGoogle Scholar
• Nouh AM, Staff I, Finelli PF. Three Territory Sign: an MRI marker of malignancy-related ischemic stroke (Trousseau syndrome). Neurol Clin Pract. 2019;9(2):124–128.
   PubMedGoogle Scholar
• Navi BB, Sherman CP, Genova R, et al. Mechanisms of ischemic stroke in patients with cancer: a prospective study. Ann Neurol. 2021;90(1):159–169.
   PubMedGoogle Scholar
• Carrier M, Lazo-Langner A, Shivakumar S, et al. Screening for occult cancer in unprovoked venous thromboembolism. N Engl J Med. 2015;373(8):697–704.
   PubMed Web of Science ®Google Scholar
• Merkler AE, Navi BB, Singer S, et al. Diagnostic yield of echocardiography in cancer patients with ischemic stroke. J Neurooncol. 2015;123(1):115–121.
   PubMedGoogle Scholar
• Chen ST, Hellkamp AS, Becker RC, et al. Efficacy and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and a history of cancer: observations from ROCKET AF. Eur Heart J Qual Care Clin Outcomes. 2019;5(2):145–152.
   PubMed Web of Science ®Google Scholar
• Melloni C, Dunning A, Granger CB, et al. Efficacy and safety of apixaban versus warfarin in patients with atrial fibrillation and a history of cancer: insights from the ARISTOTLE Trial. Am J Med. 2017;130(12):1440–1448.e1.
   PubMed Web of Science ®Google Scholar
• Key NS, Khorana AA, Kuderer NM, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol. 2020;38(5):496–520.
   PubMed Web of Science ®Google Scholar
• Agnelli G, Becattini C, Meyer G, et al. Apixaban for the treatment of venous thromboembolism associated with cancer. N Engl J Med. 2020;382(17):1599–1607.
   PubMed Web of Science ®Google Scholar
• Navi BB, Marshall RS, Bobrow D, et al. Enoxaparin vs aspirin in patients with cancer and ischemic stroke: the TEACH pilot randomized clinical trial. JAMA Neurol. 2018;75(3):379–381.
   PubMed Web of Science ®Google Scholar
• Arsava EM, Helenius J, Avery R, et al. Assessment of the predictive validity of etiologic stroke classification. JAMA Neurol. 2017;74(4):419–426.
   PubMedGoogle Scholar
• Kolominsky-Rabas PL, Weber M, Gefeller O, et al. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke. 2001;32(12):2735–2740.
   PubMed Web of Science ®Google Scholar
• Bang OY, Lee PH, Joo SY, et al. Frequency and mechanisms of stroke recurrence after cryptogenic stroke. Ann Neurol. 2003;54(2):227–234.
   PubMed Web of Science ®Google Scholar
• Boyd LA, Hayward KS, Ward NS, et al. Biomarkers of stroke recovery: consensus-based core recommendations from the stroke recovery and rehabilitation roundtable. Int J Stroke. 2017;12(5):480–493.
   PubMed Web of Science ®Google Scholar
• Frazin L, Talano JV, Stephanides L, et al. Esophageal echocardiography. Circulation. 1976;54(1):102–108.
   PubMedGoogle Scholar
• Nouh A, Mehta T, Hussain M, et al. Clot composition of embolic strokes of undetermined source: a feasibility study. BMC Neurol. 2020;20(1):383.
   PubMedGoogle Scholar
• Jickling GC, Xu H, Stamova B, et al. Signatures of cardioembolic and large-vessel ischemic stroke. Ann Neurol. 2010;68(5):681–692.
   PubMed Web of Science ®Google Scholar
• Jickling GC, Stamova B, Ander BP, et al. Profiles of lacunar and nonlacunar stroke. Ann Neurol. 2011;70(3):477–485.
   PubMed Web of Science ®Google Scholar
• García-Berrocoso T, Palà E, Consegal M, et al. Cardioembolic ischemic stroke gene expression fingerprint in blood: a systematic review and verification analysis. Transl Stroke Res. 2020;11(3):326–336.
   PubMedGoogle Scholar
• Jickling GC, Stamova B, Ander BP, et al. Prediction of cardioembolic, arterial, and lacunar causes of cryptogenic stroke by gene expression and infarct location. Stroke. 2012;43(8):2036–2041.
   PubMed Web of Science ®Google Scholar
• Mandell DM, Mossa-Basha M, Qiao Y, et al. Intracranial vessel wall MRI: principles and expert consensus recommendations of the american society of neuroradiology. AJNR Am J Neuroradiol. 2017;38(2):218–229.
   PubMedGoogle Scholar
• Roy Cardinal MH, Heusinkveld MHG, Qin Z, et al. Carotid artery plaque vulnerability assessment using noninvasive ultrasound elastography: validation with MRI. AJR Am J Roentgenol. 2017;209(1):142–151.
   PubMedGoogle Scholar
• Ropper AH. Tipping point for patent foramen ovale closure. N Engl J Med. 2017;377(11):1093–1095.
   PubMedGoogle Scholar